[Inhibition and activation of DPN-dependent zinc-containing enzymes by hypoglycemic sulfonylurea compounds].
D007004:Hypoglycemic Agents / Q000494:pharmacology*; D009243:NAD; D010088:Oxidoreductases; D013453:Sulfonylurea Compounds; D015032:Zinc
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D009243:NAD; D010088:Oxidoreductases; D015032:Zinc
ANTIDIABETICS/effects; DEHYDROGENASES
Metabolism. 1957 Jan;6(1):63-9
13386969
Proc Soc Exp Biol Med. 1956 Jun;92(2):322-4
13350335
Dtsch Med Wochenschr. 1955 Oct 7;80(40):1455-60
13261733
Metabolism. 1956 Nov;5(6 Part 2):768-73
13378045
Metabolism. 1956 Nov;5(6 Part 2):774-7
13378046
Biochim Biophys Acta. 1957 Mar;23(3):574-81
13426169
Wien Med Wochenschr. 1956 Sep 22;106(38-39):792-8
13392953
J Biol Chem. 1952 May;197(1):67-79
12981035
Experientia. 1955 Mar 15;11(3):122-8
14380246
Diabetes. 1957 Jan-Feb;6(1):41-3; discussion, 43-5
13397421
Can Med Assoc J. 1956 Jun 15;74(12 ):972-3
13329945
Biochem Z. 1957;329(1):41-7
13436412
Hemmung und Aktivierung von DPN-abhängigen Zinkenzymen durch blutzuckersenkende Sulfonylharnstoffverbindungen.